IntroductionPostoperative acute kidney injury (AKI) is a frequently observed complication after on-pump cardiac surgery (CS) and associated with adverse patient outcome. Early identification of patients at risk is essential for the prevention of CS-AKI. This study analyzed if urinary tissue-inhibitor of metalloproteinase 2 (TIMP-2) multiplied with urine insulin like growth factor binding protein 7 (IGFBP-7) is an adequate diagnostic test to identify early AKI after on-pump cardiac surgery.MethodsIn 42 patients undergoing coronary artery bypass grafting (CABG)-surgery we surveyed individual risk factors for AKI and defined AKI by applying the KDIGO-classification during surgery day and the following two postoperative days. Concentrations of urinary TIMP-2 multiplied by IGFBP-7 were recorded at four time points: at baseline pre-surgery, at the end of surgery, 4 hours after cardio pulmonary bypass (CPB) and at 8:00 am on the first postoperative day.ResultsIn total, 38% of the patients suffered from AKI. The results showed a median baseline [TIMP-2] x [IGFBP-7] concentration of 0.3 (ng/ml)2/1000, decreasing at the end of surgery, increasing at the next measure point 4 hours after CPB and further on the first postoperative day. On the first postoperative day, patients with AKI had significantly higher concentrations of [TIMP-2] x [IGFBP-7]. On the day of surgery it did not significantly differ between KDIGO 0 and KDIGO 1 to 2. Previously published cut-off points of 0.3 and 2 were not confirmed in our study cohort.Conclusion[TIMP-2] x [IGFBP-7] can be used as a diagnostic test to identify patients at increased risk of AKI after cardiac surgery on the first postoperative day. At earlier time points no significant difference in [TIMP-2] x [IGFBP-7] concentration was found between patients classified as KDIGO 0 or KDIGO 1¿2.Trial registrationGerman Clinical Trials Register (DRKS) DRKS00005457. Registered 26 November 2013.